Evidence map›Paper›PMID 18353705›Full record

ReviewCytokine & growth factor reviews2008

Transformation, translation and TRAIL: an unexpected intersection.

Shai White-Gilbertson, Semyon Rubinchik, Christina Voelkel-Johnson

Open access · greenAbstract readReview
In one paragraph

Review in Cytokine & growth factor reviews, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shai White-GilbertsonMedical University of South Carolina, Department of Microbiology and Immunology, PO Box 250504/BSB201, 173 Ashley Avenue, Charleston, SC 29425, USA. whitesh@musc.edu
Semyon Rubinchik
Christina Voelkel-Johnson
Medical University of South Carolina · US

Funding

TRAIL-induced apoptosis in prostate cancerR01CA102218 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI VOELKEL-JOHNSON, CHRISTINA · 2004 to 2008
$1.2M
NCI NIH HHS R01 CA102218
6 · The paper itself

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a cytokine with roles in tumor surveillance and tolerance. TRAIL selectively induces apoptosis in many malignant but not normal cells but the underlying cause for spontaneous TRAIL sensitivity remains elusive. We propose a novel hypothesis that links TRAIL sensitivity to translational arrest following stresses that inactivate eukaryotic elongation factor 2 (EF2). Affected cells experience a reduction in apoptotic threshold because, due to their short half-lives, levels of anti-apoptotic proteins quickly drop off once translation elongation is inhibited leaving pro-apoptotic proteins unchallenged. This change in protein profile renders affected cells sensitive to TRAIL-mediated apoptosis and places EF2 into the role of a sensor for cellular damage.

Indexed as

Cell Transformation, NeoplasticGene Expression Regulation, NeoplasticAnimalsApoptosisFree RadicalsHumansModels, BiologicalNeoplasmsProtein BiosynthesisTNF-Related Apoptosis-Inducing LigandTranscription FactorsTumor Necrosis Factor-alphaFree RadicalsTNF-Related Apoptosis-Inducing LigandTranscription FactorsTumor Necrosis Factor-alpha

Identifiers

PMID18353705
PMCPMC2323623
OpenAlexW2165714035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.